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The phosphoryl group of acetylphosphate is transferred to the membranal protein of the sarcoplasmic vesicles 
during active calcium transport. Although the phosphoprotein formed cannot be distinguished from that obtained 
in the presence of ATP, the conditions for ATP and acetylphosphate hydrolysis are different from each other. 
1. Introduction 
The phosphorylation of the membranal protein of 
the sarcoplasmic vesicles by ATP or other NTP* has 
been found to be closely connected with the activity 
of the sarcoplasmic calcium transport system [l-3] . 
The phosphoryl group transferred to the outer surface 
of the membrane is split off when the calcium is liber- 
ated inside the vesicles after the translocation across 
the membrane. 
When the membranal protein is fixed in the phos- 
phorylated state, the transferred phosphate exists, 
presumably, as an acylphosphate in the protein. The 
true nature of the phosphorylated compound which 
participates directly in the active calcium transloca- 
tion, however, remains to be ascertained. 
The recent studies that acetylphosphate (AcP) is 
hydrolyzed by kidney and brain microsomes [4,5] 
as well as by sarcoplasmic vesicles [6] may be taken as 
an argument for the assumption that an acylphosphate 
in fact is involved in ion translocation. The sarco- 
plasmic membranes are the only structure, with which 
one could demonstrate not only the hydrolysis of AcP 
but also active ion transport coupled with the AcP 
consumption. This communication describes experi- 
ments which were designed to get some information 
*Abbreviations: 
NTP : nucleoside triphosphate 
EGTA: ethyleneglycol-bis-(p-aminoethyl)-~~’-tetraacetate 
NEM : N-ethyl-maleinimide 
North-Holland Publishing Company - Amsterdam 
concerning the mode of usage of the two different 
families of energy donator during calcium transloca- 
tion by the sarcoplasmic membrane. 
2. Methods 
The vesicles of the sarcoplasmic membrane were 
prepared according to Hasselbach et al. [ 1 ] with 
slight modifications. (32P)-A~P was synthesized 
enzymatically as described by Israel and Titus [S] . 
Phosphoprotein formation and AcPase activity were 
determined under the same conditions in media con- 
taining 20 mM histidine buffer (pH 7.0) 2 mM acetyl- 
phosphate, 5 mM magnesium and 0.4 mg vesicular 
protein per ml assay. 0.2 to 0.5 mM EGTA were used 
in order to adjust the concentrations of calcium ion in 
assay. All experiments were carried out at 37”. AcPase 
activity was determined by more than three successive 
measurements of unhydrolysed AcP by the method of 
Lipmann and Tuttle [7] . The phosphoprotein forma- 
tion was measured according to Makinose [3]. 
3. Results and discussion 
As observed for ATP, the phosphoryl group 
of AcP can be transferred only if both magnesium 
and calcium ions are present in the medium (table, 
fip. 1). The magnesium ions can be replaced by 
manganese ions. Furthermore, phosphoryl transfer 
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Table 
Acetylphosphatase activity and phosphoprotein formation. 
MgCl2 
(M) 
Ca2+ 
(M) 
Modifications 
E-P 
(ctmoles/106 gprot) 
AcPase activity 
(pmoles/mg prot/min) 
0 0 _ ‘L .o 0.03 
5x1o-3 0 _ ‘L 1.0 0.15 
0 3x10-6 - % 1.0 0.03 
8.0 s12.0 oi3.5 
ADP 
2X1O-3 M 
0.7 0.03 
5x1o-3 3x1o-6 
Prenylamine 2x10” M 
NEM* 
4.7 0.2 
0.5 0.0 
Phospholipase 
A** 
0.5 s 0.7 0.52 
Ditto, washed 
with albumin 
_ 0.03 
* The vesicles were incubated with NEM (0.3 pmoles/mg prot.) for 15 min at pH 8.5 before use. 
** The vesicles were treated with one hundredth amount of phospholipase A for three hr at pH 7.2 before use. 
from both substrates is affected if the membranal free 
SH groups are blocked by NEM or if the membranal 
lipids are removed after digestion with phospholipase 
A. Under optimal conditions the steady state level of 
phosphoprotein is reached with both substrates - ATP 
or AcP - in less than three set (fig. 1). The phospho- 
protein complex isolated after acid denaturation dis- 
playes the properties of an acylphosphate - i.e. stabi- 
lity at low pH and fast decomposition with hydroxyl- 
amine at pH 5.5 - irrespectively of the phosphate 
donator. 
Fig. 2 illustrates that the amount of the phospho- 
protein formed with AcP as phosphate donator de- 
pends in nearly the same manner on the concentration 
of ionized calcium in the medium as observed in the 
ATP system. It should be noticed that the maximal 
amount of the phosphoprotein formed in the AcP 
system is 2 or 3 times higher than in the ATP system. 
The most likely explanation for the apparently low 
phosphorylation efficiency of ATP on the one hand 
and for the high efficiency of AcP on the other hand 
arises from observations of the effect of ADP. ADP, 
which accumulated inevitably more or less in the ATP 
system as a splitting product, is a potent phosphate 
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Fig. 1. Formation and decomposition of the phosphoprotein 
in the AcP assay. Initial assay: 20 mM histdine (pH 7.0), 0.2 
mM EGTA, 0.2 mM EDTA, 60 mM KCi, 2 mM AcP and 0.4 
mM membranal protein per ml assay. Additions: single arrow 
5 mM MgCla, double arrow 0.4 mM CaCla and triple arrow 4 
mM EGTA (curve I) or 2 mM ADP (curve II). Each addition 
was followed by a phosphoprotein determination within 3 sec. 
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ACP ATP 
Fig. 2. Activation of the AcP driven calcium pump by calcium ions. VP and Vca: the rate of extra-AcP consumption and calcium 
uptake respectively, extreme left ordinate. E SP: phosphoprotein formation, left ordinate. The composition of the assays is as 
described in Methods. The assay for Vca measurement contains 4 mM oxalate additionally. - - - - -, average relative activity of extra- 
ATPase, ATP driven calcium transport and phosphoprotein in the ATP assay [l-3], right ordinate. 
acceptor, while acetate isquite ineffective. Even when 
concentrations of ADP are as low as they exist in the 
presence of ATP regenerating system, the phosphoryla- 
tion level could be suppressed certainly. In agreement 
with this explanation, ITP is a phosphate donator 
which is more efficient than ATP [8], because IDP is 
also a much weaker phosphate acceptor than ADP. 
Likewise, ADP suppresses the phosphoprotein forma- 
tion in AcP system very severely (table). Fig. 1 shows 
that the addition of ADP causes a sudden and com- 
plete disappearance of the phosphoprotein formed in 
the AcP containing medium, while 30 to 40% phos- 
phate still remain attached to protein in the ATP sys- 
tem [3] . This suppression of phospoprotein formation 
in the AcP system by ADP, however, is not due to the 
action of ADP as the potent phosphate acceptor. The 
table presented shows that ADP inhibits simultaneously 
the rate of AcP decomposition. A phosphate acceptor 
could lower the level of the phosphoprotein formation 
and, consequently, inhibit the rate of inorganic phos- 
phate liberation but not the rate of the decomposition 
of AcP in the assay. After addition of ADP, AcP 
should be decomposed further on with an unchanged 
(or even enhanced) rate, if ADP would accept the 
energy rich phosphate transferred from AcP to the 
protein. 
one fifth of the maximal extra-ATPase activity (table). 
Fig. 2 illustrates that much higher calcium ion con- 
centrations are required to activate maximally the 
extra-AcPase and calcium transport in the AcP system 
than that needed to activate extra-ATPase and ATP 
driven calcium transport. When the calcium ion con- 
centration is reduced suddenly by the addition of 
EGTA, the phosphoproteirrformed from AcP decays 
with a half life time of about 120 set (fig. l), while 
in the ATP system the decay is over in a few seconds. 
As compared with ATP hydrolysis, the rate deter- 
mining reaction steps for the AcP hydrolysis required 
higher calcium concentrations and is characterized by 
a lower maximal turnover rate. 
In summary: The observations described suggest 
that the vesicles hydrolyse ATP and AcP by different 
enzymatic processes. 
The following observation supports this assumption. 
In contrast to the extra-ATPase activity, which is 
severely inhibited by prenylamine [9, lo] , the AcPase 
activity is only 40% inhibited by the drug. On the 
other hand, the phosphoprotein formation, using ATP 
as substrate, is influenced only very little by prenyl- 
amine. Using AcP as substrate, prenylamine lowers 
the formation of the phosphorylated intermediate to 
40%. 
The activity of the extra-AcPase, i.e. increment of Because prenylamine exerts its effect via the un- 
the AcP splitting rate induced by the addition of cal- saturated fatty acids such as oleic acid or arachidonic 
cium to the magnesium containing system, does not acid in the membranal lipids [ 111, this result indicates 
exceed a value of 0.2 pmoles/mg prot/min - less than that the calcium dependent ATPase activity is charac- 
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terized by another type of protein lipid interaction 
than calcium dependent AcPase activity. This conclu- 
sion is further supported by the change of the activity 
pattern produced by lipid hydrolysis. For the ATP 
system, it has been found that, after treatment with 
phospholipase A, the calcium storing capacity of the 
vesicles is destroyed, while neither the calcium mag- 
nesium activated ATPase activity nor the phosphoryl 
transfer reaction is affected. The AcP driven calcium 
accumulation is likewise destroyed by lipase digestion. 
However, the AcPase activity is enhanced by this 
treatment while, at the same time, the level of phos- 
phoprotein formed is strongly reduced (table). A 
similar activity pattern has been observed for the in- 
teraction of ATP with sarcoplasmic membranes after 
lipid depletion and reconstitution by lysolecithine [9]. 
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